p27 Kip1 is a cyclin-dependent kinase inhibitor whose down-regulation has been observed in several tumour models, including breast, colorectal, and gastric carcinomas. The purpose of this study was to assess p27 Kip1 protein expression in normal and benign prostatic epithelia as well as the possible
Combined c-Myc and caveolin-1 expression in human prostate carcinoma predicts prostate carcinoma progression
✍ Scribed by Guang Yang; Terry L. Timme; Anna Frolov; Thomas M. Wheeler; Timothy C. Thompson
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 252 KB
- Volume
- 103
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Galectin-1, a member of the beta-galactoside-binding galectin family, is a pleiotropic dimeric protein participating in a variety of normal and pathological processes, including cancer progression. Modulation of the interactions with the basement membrane glycoprotein laminin and induction of apopto
## BACKGROUND. The cyclin D1 gene is amplified and/or overexpressed in several types of human cancer, including cancers of the breast, esophagus, head, and neck. However, the role of cyclin D1 in prostate cancer has not been previously studied in detail. METHODS. Six human prostate cancer cell lin
## Abstract ## BACKGROUND The authors previously identified elevated caveolin‐1 expression in human prostate carcinoma and determined that caveolin‐1 levels as detected by immunohistochemistry of radical prostatectomy specimens offered novel prognostic information. A higher incidence of caveolin‐1
## Abstract Carcinoma‐associated fibroblasts (CAF) promote tumor progression of pre‐neoplastic epithelial cells. To investigate the basis of this phenomenon, we compared the properties of fibroblasts cultured from normal human prostate (NHPF) to prostate CAF. NHPF and CAF were assayed for growth po
Overexpression of cyclooxygenase (COX)-2 has been implicated in many pathologic conditions, including cancer. One practical inference of this finding is that sustained inhibition of COX-2 could serve as a promising target for prevention or therapy of cancer. Conventional nonsteroidal antiinflammator